| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.042 | 0.6 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |